- Home
- PROK
PROK
ProKidney Corp.
as 08-14-2025 3:40pm EST
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | WINSTON-SALEM |
| Market Cap: | 384.2M | IPO Year: | N/A |
| Target Price: | $6.25 | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.46 - $7.13 | Next Earning Date: | 08-12-2025 |
| Revenue: | $527,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 105.78% | Revenue Growth (next year): | N/A |
Latest ProKidney Corp. News
PROK Breaking Stock News: Dive into PROK Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 months ago
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights
Argus Research
4 months ago
Daily – Vickers Top Buyers & Sellers for 04/25/2025
Argus Research
4 months ago
Daily – Vickers Top Buyers & Sellers for 04/22/2025
Argus Research
4 months ago
Daily – Vickers Top Buyers & Sellers for 04/21/2025
Argus Research
4 months ago
Daily – Vickers Top Buyers & Sellers for 04/18/2025
Argus Research
4 months ago
Daily – Vickers Top Buyers & Sellers for 04/17/2025
Simply Wall St.
5 months ago
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation
Zacks
5 months ago
Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK)
Compare PROK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PROK ProKidney Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.